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ReviewGlossary
Cre recombinase: Enzyme that recognizes, binds to, cuts and religates specific
DNA sequences (called LoxP sequences). Four copies of Cre recombinase bind
to two LoxP DNA sequences, and then Cre recombinase exchanges one strand
each from the two LoxP sequences. If the two LoxP sequences are present on
two different DNA molecules, then these will be conjoined as a result, resulting
in one DNA molecule with two LoxP sites.
Homing endonucleases: Restriction enzymes with particularly long (20–30 base
pairs) recognition sequences. After cutting the DNA, they often leave four-
nucleotide overhangs that can be compatible with overhangs generated by
another restriction enzyme, BstXI; then, DNAs processed with homing
endonucleases can be efficiently ligated to DNAs tailored by BstXI. Both
recognition sequences are destroyed in the process, and the ligation product
cannot be cut by either enzyme.
Ligation independent cloning (LIC): A method for inserting DNA sequences
(i.e. genes) into a plasmid DNA molecule without using DNA ligase. DNAs to
be conjoined are treated by exonucleases that trim back one strand of the
DNA double helix, exposing the complementary strand as a long sticky end.
If two DNA molecules have complementary sticky ends, they can be
conjoined simply by mixing. LIC methods have become popular in recent
years because they do not require preselected DNA sequences that serve as
recognition sites for restriction enzymes. A version of LIC that is entirely
independent of any DNA sequence is called SLIC (sequence and ligation
independent cloning).
LoxP sequence: Short imperfect inverted repeat of 34 base pairs which serves
as a recognition site, cleavage site and religation site for Cre recombinase. The
LoxP sequence is not symmetric, therefore, the conjoining of two LoxP
sequences by Cre recombinase is directional.
Nuclear polyhedrosis virus (NPV): NPV attacks caterpillars, such as the larvae
of the alfalfa looper or the silkworm. NPVs are highly specific for their host and
thus useful as pest control agents.
Polyprotein: Long polypeptide which contains several individual proteins that
are connected by linker amino acids which either are capable of self-cleavage,
or are recognition and cleavage sites of highly specific proteases.
Tn7 transposon: Originally discovered as a large (14 kb) DNA segment from
Tn7 phage, which can insert into a specific location in the E. coli genome. The
transposon encodes the Tn7 transposase, a four-subunit protein complex that
carries out this insertion reaction. Three DNA elements are minimally required
for this reaction: the Tn7L and Tn7R DNA sequences which flank the DNA to be
transposed, and a sequence called Tn7 attachment site (attTn7) into which the
transposed DNA is inserted. This insertion mechanism can be efficiently
exploited to conjoin recombinant DNA by providing the Tn7L and Tn7R
sequences on a plasmid at each end of a DNA sequence of interest, and theProtein complexes composed of many subunits carry out
most essential processes in cells and, therefore, have
become the focus of intense research. However, deci-
phering the structure and function of these multiprotein
assemblies imposes the challenging task of producing
them in sufficient quality and quantity. To overcome this
bottleneck, powerful recombinant expression technolo-
gies are being developed. In this review, we describe the
use of one of these technologies, MultiBac, a baculovirus
expression vector system that is particularly tailored for
the production of eukaryotic multiprotein complexes.
Among other applications, MultiBac has been used to
produce many important proteins and their complexes
for their structural characterization, revealing funda-
mental cellular mechanisms.
Multiprotein complexes catalyze cellular function
Our understanding of cellular function has remarkably
expanded in recent years, brought about by technological
advances in DNA and protein analysis [1]. The sequencing
of complete genomes, such as the human genome, has set
the stage to address proteome-wide interaction studies,
which have revealed that proteins do not typically exist as
isolated entities [2–4]. Rather, they are assembled in com-
plex molecular machines consisting of numerous proteins
and, often, other biomolecules (such as nucleic acids,
sugars, lipids and small molecules), arranged into func-
tional modules that catalyze essential cellular processes.
This molecular organization has been recently termed
‘protein sociology’ [5].
Understanding cellular processes requires detailed
knowledge of the 3D structure of the molecules involved,
and the parameters and architectural features that dictate
their interaction. Structural genomics efforts strive to ana-
lyze comprehensively single proteins and protein domain
structures on a whole-genome scale, and have provided
atomic structures of thousands of protein structures and
folds. Furthermore, the architectures of essential macromo-
lecular complexes, such as ribosomes, nucleosomes and
RNA polymerases, have been revealed at near atomic reso-
lution, providing a wealth of structural detail and crucial
insight into the functions of these multicomponent
machines [6–8]. Integrated approaches combining structur-
al, functional and computational data are emerging, andCorresponding author: Berger, I. (iberger@embl.fr).
0968-0004/$ – see front matter  2011 Elsevier Ltd. All rights reserved. doi:10.1016/j.tibs.2011.provide views of protein organization in space and time in
entire organisms [5,9].
Notwithstanding, our molecular understanding of the
very large number of protein complexes in the cell remains
limited to a handful of examples for which detailed near-
atomic structures are known. This is mostly because of the
difficulty in obtaining samples in sufficient quality and
quantity for molecular studies. Many essential complexes
remain intractable because they exist in very low amounts
in their endogenous host, which hinders their purificationattTn7 sequence on another DNA which will serve as recipient. The reaction is
started by addition of the transposase to these DNAs.
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can resolve this bottleneck, and numerous expression sys-
tems, mostly for heterologous protein expression in Escher-
ichia coli, have been developed and refined over the past
few decades. More recently, E. coli expression systems
have been designed for coexpression of several proteins
by using polycistronic mRNA transcripts, or two or more
plasmids that coexist in the same cell [10,11] (Box 1).
However, many eukaryotic protein complexes cannot beBox 1. Coexpression toolbox for production of protein complexe
Expression systems for production of protein complexes in E. coli
frequently make use of polycistronic expression cassettes with
several genes of interest, spaced apart by ribosome binding sites
(Shine–Dalgarno sequences), placed under the control of a single
promoter, and typically followed by a sequence for efficient termina-
tion of mRNA transcription [10,11,21,60–62] (Figure Ia). In eukaryotic
hosts, an analogous design can involve internal ribosomal entry sites
(IRESs), which are inserted between gene coding regions under
control of a single promoter [24–27] (Figure Ib). IRESs exist in the 50-
untranslated regions of many viral and cellular mRNAs [24], and
facilitate cap-independent translation by recruiting ribosomes for
efficient protein production. IRES sequences differ greatly and exhibit
species specificity [26]. For example, IRES elements from encephalo-
myocarditis virus (EMCV) work well in mammalian cells, whereas
IRESs from Perina nuda virus (PhV) and Rhopalosiphum padi virus
(RhPV) have been successfully used for protein complex production
in insect cells [27].
Polyproteins are long polypeptides containing individual proteins
spaced by specific proteolytic cleavage sites. Certain viruses, such as
coronavirus, produce their entire proteome by proteolytic processing
of polyproteins encoded by a few open reading frames. Polyprotein
approaches have proven to be particularly powerful for balancing the
stoichiometry of coexpressed proteins [22,28–30] (Figure Ic). Poly-
protein constructions can involve self-cleaving peptides found in
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Figure I. Tools for expression of protein complexes. (a) Protein complexes can be prod
are spaced apart by ribosome binding sites (rbs) and placed under control of a single 
One or several polycistrons can be provided on one or more plasmids simultaneousl
IRESs instead of rbs, resulting also in polycistronic mRNAs. (c) Polyproteins are par
constructions can provide self-cleaving peptides derived from picornavirus (2A) in 
included to facilitate tracking of heterologous expression from the respective promote
contain a highly specific protease [here tobacco etch virus (TEV) Nla], which processes
individual proteins including itself (bottom). Both polyprotein strategies have the dra
residues that are part of the cleavage sequence (boxed). Asterisks denote sites of clea
underlined.
50produced efficiently in E. coli. They may contain subunits
that are too large for the E. coli transcription and transla-
tion machinery, or may require either specific chaperone
systems for proper folding or protein modifications (such as
phosphorylation or acetylation) that E. coli cannot provide.
Thus, the successful overproduction of these complexes,
which is required to decipher their structure and function,
depends on the availability of powerful eukaryotic expres-
sion technologies. In this review, we describe MultiBac, as
picornavirus (called P2A peptides) or variants thereof [28,29].
Alternatively, constructions can be used that mimic open reading
frames in positive-sense single-stranded RNA viruses and provide a
highly specific protease gene together with genes of interest arranged
in a single large open reading frame [22,30]. Individual proteins are
then liberated from the encoded polyprotein by the protease, which
cleaves the proteolytic sites placed between the protein subunits
(Figure Ic).
The elucidation of protein–protein interactions in complexes is of
crucial importance for many applications including structural biology.
A novel approach, CoESPRIT, utilizes library-based construct screen-
ing for the identification and expression of soluble protein complexes
in E. coli [31]. In CoESPRIT, a subunit of a (putative) protein complex
is provided as bait. The interacting partner is provided in the form of a
random incremental library generated by exonuclease digestion of
the full-length gene. Prior input from bioinformatics analyses such as
homology alignments or domain identification is not required for this
approach. Coexpression of the library with the bait protein allows
identification of soluble complexes by immunofluorescence-assisted
colony screening using labeled antibody markers against affinity tags
present on the proteins screened. Production of protein complex from
high-expressor colonies thus identified can then be scaled up to
milligram amounts for high-resolution studies by NMR or X-ray
crystallography [31].
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uced efficiently in E. coli by using polycistrons. In polycistrons, genes of interest
promoter (Prom). A sequence (Term) ensures termination of mRNA transcription.
y in one cell. (b) The equivalent construction for eukaryotic expression provides
ticularly useful to balance the stoichiometry of expressed proteins. Polyprotein
between the individual proteins (top). A fluorescent protein (here CFP) can be
r by fluorescence measurement. As an alternative, polyproteins can be used that
 the polyprotein by cleaving corresponding cleavage sites (tcs), thus liberating the
wback of decorating the C terminus of the preceding protein with overhanging
vage. Conserved residues defining the site are in bold. C-terminal overhangs are
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designed to tackle and overcome this crucial production
bottleneck [12,13]. We summarize the technology concepts
underlying MultiBac and review its wide range of applica-
tions.
The MultiBac system
Yeast, mammalian cells and insect cells have been suc-
cessfully used for recombinant production of eukaryotic
proteins [14]. In particular, the use of insect cell cultures
infected by a recombinant baculovirus, carrying the eu-
karyotic gene of interest, was first demonstrated many
years ago [15]. The exciting evolution of baculovirus from
a pest control agent to a powerful recombinant protein
production tool has recently been reviewed [16], and bacu-
lovirus expression systems have become increasingly pop-
ular for many applications [17–19].
MultiBac is a baculovirus expression system particu-
larly designed for the production of eukaryotic multipro-
tein complexes with many subunits (Figure 1). It consists
of an array of small synthetic DNA plasmids, an engi-
neered baculovirus genome derived from the Autographa
californica nuclear polyhedrosis virus (AcNPV; see Glos-
sary) that is used to infect cells of the caterpillar Spodop-
tera frugiperda, and a set of protocols detailing every step
from gene insertion into the plasmids to production of
protein complexes in cultured insect cells [19,20]. The
presence of many subunits in a protein complex requires
the assembly of many encoding genes and their integra-
tion into the baculovirus in a multicomponent co-produc-
tion experiment. This process is laborious and technically(a)
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Figure 1. The MultiBac system. MultiBac is a baculovirus expression vector system part
MultiBac consists of an array of small (3 kb), synthetic DNA plasmids called acceptors a
have a conditional origin derived from R6Kg phage (oriR6kg) that requires special bacteri
controlled by late baculoviral promoters (polh or p10) as well as strong eukaryotic poly
(circles filled in red) for fusing donors to an acceptor by the Cre recombinase. Each plasm
either chloramphenicol (CmR), kanamycin (KnR) or spectinomycin (SpR) resistance for d
several expression cassettes on a donor or acceptor based on specifically designed restr
as blue boxes flanking promoter and terminator, respectively) [18,19,21]. Acceptors co
transposase. (b) The assembly of a composite MultiBac baculoviral genome for mult
restriction endonucleases and ligase, or sequence-independent and ligation-indepe
construction that is inserted into the baculoviral genome by Tn7 transposition in specifi
DNA located between the Tn7R and Tn7L sequences in the multigene fusion construct is
MultiBac baculovirus was engineered for improved protein production and delayed host
independent cloning (SLIC) for gene insertion and Cre–LoxP fusion for multigene co
parallelized mode on microtiter plates, optionally on a robot [21]. Further heterologous g
baculoviral DNA is then purified from the bacteria and used to transfect insect cells. 
harvesting the budded virus particles released into the culture media. This virus is then 
cell cultures [13,20].challenging using conventional methods that typically
involve serial insertion of genes into increasingly large
and difficult-to-handle DNA plasmids. MultiBac applies a
different concept for multigene assembly that relies on
recombination of small, custom-designed, synthetic DNA
plasmid molecules (< 3 kb) that are called ‘acceptors’ and
‘donors’ (Figure 1a).
Acceptors and donors can be easily loaded with one or
several genes each, and recombined in a single-step reac-
tion into a multigene construct. Acceptors contain an
origin of replication that allows propagation in standard
cloning strains of E. coli, whereas donors harbor a condi-
tional origin of replication (derived from phage R6Kg) that
requires the presence of a specific protein (known as p) for
replication. This protein is expressed from the pir gene
inserted into the chromosome of specifically tailored E. coli
strains that are used to propagate donor plasmids [13,20].
Donors and acceptors contain a resistance marker, a short
imperfect inverted repeat (LoxP), an expression cassette
consisting of a baculoviral promoter (p10 or polh), a DNA
segment for inserting heterologous genes, and an efficient
signal for eukaryotic polyadenylation (Figure 1a). The
expression cassettes are flanked by a homing endonucle-
ase site and a compatible BstXI site, which allow for
iterative assembly of several expression cassettes on each
plasmid [21].
Importantly, donors can survive in a pir-negative back-
ground only if they are conjoined with an acceptor that
provides a nonconditional origin of replication, and this is
the central feature that enables flexible and efficient gen-
eration of multigene constructs. These are achieved in vitro(b)
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 cell lysis by deleting specific genes [12]. The combination of sequence and ligation
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Figure 2. MultiBac expression for structural biology. The MultiBac system has
been successfully used to produce many proteins and their complexes in high-
quality for structural analysis. The structures of LKB1–STRADa–MO25a (PDB
2WTK) [55], a tumor suppressor kinase complex, the PKCbII kinase (PDB 3PFQ)
[32], and the Rad9–Rad1–Hus1 complex, a DNA damage checkpoint complex (PDB
3G65) [56], were determined by X-ray crystallography providing crucial insight into
the function of these important proteins. The crystal structure of the N-terminal
domain (NTD) of the chromatin remodeler Mot1 bound to the TATA-box binding
protein (TBP) showed a molecular bottle-opener for TBP (PDB 3G65) [57,58]. In a
hybrid approach involving EM and X-ray crystallography, a structure of a different
chromatin remodeling enzyme, ISW1 (lacking the ATPase domain), bound to a
nucleosomal template was elucidated (PDB 2Y9Z and EMD-1877) [33]. Strikingly,
the entire 13 subunit yeast APC/C, an E3 ubiquitin ligase essential for the cell cycle,
was assembled by MultiBac (Box 3) as well as two multisubunit APC/C
subcomplexes (TPR5 and SC8), leading to structures revealing many details of
APC/C assembly by EM (EMD-1844, 1841 and 1845) [34]. Molecular illustrations
were prepared with PyMOL (http://www.pymol.org/).
Review Trends in Biochemical Sciences February 2012, Vol. 37, No. 2by Cre recombinase, which fuses one or several donors
(each with one or several inserted genes) to a single accep-
tor in a one-step reaction by conjoining via the LoxP sites;
this results in plasmid dimers, trimers and tetramers. The
resulting multigene expression constructs are character-
ized by the precise combinations of resistance markers
present on the fusions, and this can be exploited for com-
binatorial assembly strategies based on multiple antibiotic
selection [21]. The process of inserting genes into acceptors
and donors, which can be optionally done by ligation
independent methods followed by Cre–LoxP fusion, is
termed ‘tandem recombineering’ [22].
Gene insertions into the MultiBac genome take place in
bacterial strains that contain the MultiBac viral genome as
an artificial chromosome together with a plasmid encoding
the Tn7 transposon enzyme complex. Multigene acceptor–
donor fusion constructs are transformed into these bacte-
rial cells, and the Tn7 transposon enzyme inserts the
collection of expression cassettes present on the accep-
tor–donor fusion in a single-step reaction into the Tn7
attachment site engineered into the baculoviral genome
(Figure 1b). Productive transposition disrupts a LacZa-
encoding gene, which enables blue/white screening of colo-
nies. The MultiBac baculoviral genome has been engi-
neered for improved protein complex production by
removing genes encoding viral protease and apoptotic
activities, thereby reducing proteolytic breakdown of the
heterologous gene products and delaying lysis of the
infected cells [12,13]. As a second site of entry in addition
to the Tn7 attachment site, the MultiBac genome contains
also a distal LoxP site for adding further functionalities.
For example, a gene encoding l-phosphatase was inserted
into this site to remove phosphates from a coexpressed
protein complex [23]. The composite MultiBac virus is then
purified and used to transfect insect cells for protein pro-
duction in Petri dishes containing cell monolayers or, for
larger volumes, shaker flasks containing suspension cul-
tures [13,19,20]. MultiBac resolves several challenges en-
countered in protein complex production. These include
constraints on handling many and often very large encod-
ing DNAs and the necessity to revise expression experi-
ments rapidly and flexibly if a subunit or purification tag
needs to be altered or exchanged, by replacing the respec-
tive donor or acceptor with a modified version in the
tandem recombineering pipeline.
In addition to MultiBac, a growing number of technolo-
gies are currently being used for expressing protein com-
plexes (Box 1). Examples of these approaches are the use
of internal ribosome entry sites (IRESs) for multigene
expression, and the use of polyprotein constructions in-
volving self-cleaving peptide sequences or proteolytic pro-
cessing of large precursor polypeptides by specific
proteases [22,24–30]. Particularly promising for structur-
al biology, where often a large number of constructs need
to be scrutinized in parallel, are new methods coupling
gene libraries to coexpression (Box 1) [31]. These
approaches are compatible with the MultiBac technology
concept; for example, the polyprotein approach has been
successfully used to produce a human transcription factor
core complex by MultiBac, with improved production effi-
ciency and yield [22].52MultiBac expression of protein complexes for structural
studies
The MultiBac system, originally designed by X-ray crystal-
lographers interested in studying multiprotein complexes
[12], has been well received and put to good use by the
structural biology community (Figure 2, Box 2). Many
proteins and their complexes have been produced by Multi-
Bac, often for the first time, for structure elucidation,
providing important insight into their biological function
(Figure 2). In some cases, for example for producing intact
full-length protein kinase CbII, an existing transfer plas-
mid was combined with the optimized MultiBac baculo-
virus genome for protein production [32]. The modular
concept of gene assembly by tandem recombineering has
turned out to be instrumental for accelerating the process
of obtaining high-quality samples for structural biology of
numerous complexes [33–36].
Two outstanding examples of the utility of MultiBac are
the elegant production of the entire anaphase promoting
complex, APC/C – a large (1.1 MDa) 13-subunit multiprotein
assembly that regulates defined cell cycle transitions [34] –
and the recent crystal structure elucidation of the Mediator
head module – a transcription factor complex that is essen-
tial for the expression of class II genes in eukaryotes [35].
The gene assembly encoding the complete APC/C was
inserted into two MultiBac baculoviruses, encoding eight
and five subunits, respectively. Co-infection of insect cells
with the two viruses allowed the purification of the entire
1.1-MDa complex and its structural determination by elec-
tron microscopy (EM), revealing the structural basis for
subunit assembly (Figure 2) [34]. The production of the
Mediator head module from yeast (seven subunits, 223
Box 2. Crystal structure of the Mediator head module
Mediator is a large multiprotein complex that is central to gene
expression in eukaryotes and is organized into three modules termed
head, middle or arm, and tail [63]. The size and complexity of
Mediator has long posed a major challenge for structural studies.
Mediator head (seven subunits, 223 kDa) was first successfully
produced recombinantly by infecting insect cells with single baculo-
viruses, each encoding one subunit, opening the door for structural
studies [36]. However, this procedure required lengthy optimization to
indentify suitable, highly producing recombinant baculoviruses by
repeated rounds of laborious screening – a process of 8 weeks or
longer for each baculovirus. The demanding procedures constrained
logistics and severely compromised attempts at structure determina-
tion of Mediator head by X-ray crystallography, which typically
necessitates flexible, stream-lined and efficient production protocols
for generating many variants of the protein specimen studied. The
MultiBac system elegantly resolved this fundamental impediment
[35]. All genes encoding the subunits of the Mediator head module
were inserted into a single MultiBac baculovirus by using tandem
recombineering [36,64]. Combinatorial assembly of the genes lead to
a series of MultiBac baculoviruses encoding either full Mediator head
(Med17, Med6, Med18, Med8, Med20, Med11 and Med22) or
subcomplexes including core head (Med17, Med6, Med8, Med11
and Med22) and mini head (Med17, Med11 and Med22). Investigation
of these complexes by EM allowed initial assignment of subunit
positions [64]. Modification of Med17 and Med18 by eliminating
flexible regions was crucial to obtain diffraction-quality head module
crystals, and this was easily accomplished by simply exchanging the
respective unmodified genes in the original MultiBac baculovirus
expressing the full head [35]. The modular acceptor–donor construc-
tion principle of MultiBac is crucial to facilitate this alteration,
alleviating a need to assemble the entire multigene construct every
time again de novo. The recombinant head module has been purified
and crystallized, and the architecture of this 223-kDa complex has
been determined by X-ray crystallography (Figure I). The crystal
structure of the Mediator head reveals how this essential complex is
built from its components to provide stability as well as flexibility for
transcription regulation, resulting in a platform for other transcription
factors [35]. Notably, a portion of the head named ‘neck domain’
confers stability and integrity of the complex by forming a striking,
novel multihelical bundle, engaging five of the seven subunits of
Mediator head.
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Figure I. Architecture of Mediator head. The seven-subunit, 223-kDa complex
was produced by MultiBac, crystallized and the X-ray structure determined [35].
(a) A representative gel section from SDS-PAGE showing the quality of sample
prepared. (b) The crystal structure in a schematic view (top) and in an identically
color-coded ribbon representation superimposed on the experimental electron
density (bottom). Density is displayed at 4 A˚ resolution (contoured at 1.5 s).
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tion of the MultiBac system, is detailed in Box 2 [35].
Clearly, MultiBac is only one of many tools that bring
such studies to fruition. Nonetheless, quality sample prep-
aration is a crucial component of the structural determi-
nation pipeline. The studies already available exemplify
the aptitude of the system, and hint at recurring challenges
encountered when using MultiBac in multiprotein complex
research (Box 3). The list of illuminating structures of
complexes produced by using MultiBac can be expected
to grow rapidly in the future.
Complexes come in many forms: the coatomer
Proteins and their complexes in their native tissue can exist
as several isoforms, which may complicate their biochemical
and structural characterization when extracted and purified
from endogenous source material by immunoprecipitation
or classical biochemical approaches. An example is the
coatomer, the central protein component that covers certain
vesicles, known as coat protein I (COPI)-coated vesicles,
which are thought to play an important role in the early
secretory pathway. Coatomer consists of seven subunits and
exists in four isoforms of different subunit composition. The
four isoforms co-purify when extracted from animal tissue,
which hampers their structural analysis and impedes
attempts to understand the potentially different functions
of the individual isoforms. For example, it remains unclear
whether or not COPI-coated vesicles are uniformly coated
with individual isoforms, although these have been found to
be unequally distributed in the Golgi stack [37].Recently, all four coatomer isoforms have been success-
fully produced using MultiBac, setting the stage to indi-
vidually address their structure and function [38]. This has
been achieved by integrating the genes encoding the five
subunits that are common to all isoforms into the Tn7
attachment site of the MultiBac viral genome. The genes
for the other two subunits, which are variable and define
the four isoforms, were inserted by using a donor plasmid
into the LoxP site that is distal to the Tn7 attachment site
on the MultiBac viral genome. Coatomer complex isoforms
can then be purified successfully from insect cell cultures
infected with the respective MultiBac virus [38].
A MultiBac silkworm bioreactor
Silkworms, the larvae of the moth Bombyx mori, have been
used for thousands of years to produce silk for textile
production, but they have gained a new role as protein
production bioreactors after the successful expression of
human a-interferon in these insects. A growing number of
proteins, including interleukins and antibodies, have since
been produced using this system [39,40]. Interestingly, it
seems that silkworms can sometimes produce much higher
yields of recombinant proteins than can be obtained from
liquid cell cultures. For example, the activity of interleu-
kin-3 produced in silkworms is 10 000-fold higher than that
produced in cultures of immortalized African green mon-
key kidney (COS) cells, and 30-fold higher than that pro-
duced in insect cell suspension culture. Notably, 1 mg of
purified human macrophage colony-stimulating factor can
be extracted from 10 silkworms [39].53
Box 3. MultiBac debugged: challenges and solutions
A multitude of factors can compromise the production of multi-
protein complexes. Among the major impediments are:
Insufficient knowledge of the composition of the complex.
Recombinant production of such a complex by coexpression will
invariably fail if a subunit crucial for complex integrity has not been
properly identified in original preparations. Although proteomics
and genomics technologies increasingly contribute to improve and
validate the data available (reviewed in [1]), protein complex
coexpression can already reveal important information about
interacting partners even if the (presumed) complete complex
cannot be obtained.
Post-translational modifications (PTMs). PTMs such as phos-
phorylation and acetylation can be essential for proper assembly of
a complex or for its activity. Thus, the modification activity needs to
be either coexpressed or supplied during purification. An addi-
tional problem is that insect cells may decorate proteins with
nonphysiological PTMs (frequently phosphorylation), which com-
promise complex formation or activity. Therefore, mutations that
abolish the modification activity must be introduced in the host
genome, or enzymes (such as l-phosphatase) that remove the
modification have to be coexpressed or supplied [23]. Alterna-
tively, inhibitors of the particular modifying enzyme (if known) can
be added to the growth media if compatible with cell growth and
protein production.
Complex instability. Coexpression of an entire complex from a
single virus may not be the ultimate solution. For example, a
complex may dissociate during purification in a salt gradient. It may
be worth identifying exactly what components dissociate during
purification; stable subcomplexes may then be produced separately
to reconstitute the complex in vitro by choosing proper conditions.
Effort required to place all subunit genes on a single baculovirus.
For very large complexes, this may be challenging, and applying co-
infection with a small number (two or three) of multigene viruses
instead may be a viable option.
Virus instability. This is a drawback of every baculovirus
expression system, because baculoviruses deteriorate during
amplification and passaging. Gene deletions, notably affecting
heterologous DNA inserts, can potentially abolish complex produc-
tion. To minimize such deleterious events, specific protocols have
been delineated [13,20], and new approaches to overcome viral in
stability by genome engineering are being developed [65].
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ment of a version of the MultiBac system adjusted for
protein complex production in a silkworm bioreactor
[41]. In this system, the original baculovirus genome
was replaced with that of a B. mori nuclear polyhedrosis
virus (BmNPV), likewise provided as an artificial chromo-
some in bacterial cells. A Tn7 attachment site was intro-
duced into this BmNPV genome, and a plasmid expressing
the Tn7 transposon complex was co-transformed. Thus, the
silkworm MultiBac system retains the ability to accept
multigene vector constructions prepared by tandem recom-
bineering or by conventional restriction and ligation clon-
ing. A distinct feature of the B. mori MultiBac system is the
method of infecting the silkworms, which occurs via injec-
tion of virus solution with a needle. Protein complexes are
then purified from the hemolymph of infected silkworms
after several days.
Recombinant human DNA polymerase d has been pro-
duced using silkworm MultiBac [41]. Although the enzyme
is thought to contain four subunits, the extraction from
animal tissue usually leads to loss of two subunits during
purification. Four milligrams of active enzyme containing
all four subunits can be purified from 350 silkworms
infected with a silkworm MultiBac virus carrying four54genes, providing a simple, fast, reliable and economic
platform to produce human DNA polymerase d. Therefore,
the silkworm MultiBac system might be useful for the
production of other protein complexes, especially if an
economic option for protein production is required.
Extending the concept to mammalian cells
The concept of multigene delivery of fused acceptor and
donor plasmids, each carrying one or several genes, is not
restricted to baculovirus expression systems. Originally,
tandem recombineering was developed for generating mul-
tiexpression plasmids for production of protein complexes
in E. coli to alleviate imbalances in expression levels
observed with multiplasmid co-transformation [21]. Ex-
pression of protein complexes in mammalian cells can be
achieved by transfection with multiple plasmids, in analo-
gy to multiplasmid co-transformation in E. coli. However,
this approach can lead to imbalanced production from the
plasmids and to heterogeneous cell populations with dif-
ferences in the ratio of plasmids incorporated. This imped-
iment can be efficiently resolved by using a single plasmid
that contains all the heterologous genes. This multigene
plasmid can be conveniently generated by tandem recom-
bineering of properly modified acceptors and donors, in
which the baculoviral promoters are exchanged for mam-
malian promoters [22,42]. The resulting multigene plas-
mid is introduced into mammalian cells by using a
transfection reagent [42].
The efficacy of this approach was demonstrated in a
study where an assortment of proteins, systematically
tagged with fluorescent markers, was expressed transient-
ly or stably in animal tissue cells [42]. This MultiBac-
derived system, called MultiLabel, can be used for simul-
taneously visualizing proteins and their actions in homo-
geneous cell populations by tracking the fluorescent
signals. Importantly, the ratio of the heterologous proteins
is constant at the single-cell level. MultiLabel has been
recently implemented to dissect the interactions of epider-
mal growth factor receptor (EGFR), Rab GTPases and
phosphoinositol phosphates, which are components of
membrane trafficking processes [42,43].
Gene therapy for obesity?
Gene therapy involves either the targeted delivery of one or
several wild-type genes that replace or substitute in for
disease-causing genes (which bear aberrant mutations)
and produce the desired gene products. or the delivery of
genes encoding therapeutic proteins that prevent, modu-
late or correct the disease [44]. Baculoviruses have been
intensively studied as potential delivery vectors for gene
therapy because they transduce mammalian cells efficient-
ly, do not seem to be toxic, and are nonhazardous (for the
target cells and for those carrying out the experiment) as
they do not replicate in mammalian cells [17,45,46]. Fur-
ther advantages are the ease of producing baculoviruses
and the large tolerance for heterologous gene insertions
into the viral genome without compromising virion integ-
rity. However, there are formidable obstacles to overcome,
such as the observed inactivation of baculoviruses by the
human complement system and the lack of specificity with
respect to cell types transduced. These problems have not
Review Trends in Biochemical Sciences February 2012, Vol. 37, No. 2satisfactorily been resolved, therefore, baculoviruses have
not yet played a major role as gene therapy vectors.
By contrast, recombinant adeno-associated virus
(rAAV) does not have the drawbacks of baculovirus and
is currently the best choice for efficient gene delivery for
gene therapy [47]. However, clinical grade production of
rAAVs, which are necessarily rendered replication incom-
petent, remains a major impediment for the field. A highly
efficient scale-up protocol for rAAV production utilizes
recombinant baculoviruses to produce gene-therapy-com-
petent rAAV particles in insect cell cultures [48–51]. This
protocol involves three recombinant baculoviruses that
carry genes encoding different components of rAAV andrAAV-Bac
Bac-Rep Bac-VP
Triple virus
co-infection
Purification
Sf9 cells
Leptin rAAV vector
for gene therapy
Injection
AAV virion
coat proteinsREP78,REP52Δ
AAV ITR
Rat leptin cDNA
oriR6Kγ
Chicken  β-actin
promoter
LoxP Donor
TiBS 
Figure 3. Application of the MultiBac system in gene therapy. rAAV particles are
produced by co-infection with three different baculoviruses [48,49]. Bac-Rep
harbors two expression cassettes that contain genes for the major AAV replication
enzyme, Rep78, and an N-terminal truncation of Rep78, Rep52D. rAAV-Bac
contains AAV inverted terminal repeat (ITR) elements that are required for
rescue, replication and packaging of transgene sequences, together with rat
leptin cDNA under the control of a chicken b-actin promoter, which is inserted into
the rAAV-Bac baculoviral genome by Cre–LoxP-mediated fusion of a specifically
tailored donor plasmid [52]. Leptin is a hormone that acts in the brain to reduce
food intake and stimulate energy expenditure. Bac-VP produces the AAV virion
coat proteins. Complete rAAV virions containing the leptin gene are produced in
triply co-infected insect cells and purified [50,52], and then administered to diet-
induced obese rats. An obese rat is shown compared to a normal rat for illustration
(bottom). Diet-induced obesity renders laboratory rats (and presumably other
species) resistant to leptin treatment. Therefore, it is close to impossible to curtail
diet-induced weight gain. This could be overcome by circumventing leptin
resistance or restoring leptin actions in obese animals. The surprising outcome
of the study involving baculovirus-produced leptin rAAV as a gene therapy vector
was that exercise, in this study wheel-running, was required to prevent completely
weight gain when combined with the leptin gene therapy intervention, leading to
the conclusion that work-out, in tandem with leptin gene delivery, may actually
develop into a potential antiobesity treatment [52]. The baculovirus schematic
drawing is adapted from an image kindly supplied by K. J. Airenne (University of
Kuopio, Finland). The rAAV particles shown are based on PDB entry 1LP3 [59].the transgene to be delivered (Figure 3). Co-transfection of
insect cells with the three baculoviruses results in the
assembly of intact rAAV particles, which can be further
processed and purified to achieve clinical grade.
A particularly noteworthy recent study has involved the
production of rAAV particles for gene therapy of obesity in
laboratory rodents (Figure 3) [52]. The rAAV administered
to laboratory rats fed on a high-fat diet contained leptin
cDNA as the transgene, introduced into the MultiBac
baculoviral genome via Cre–LoxP fusion of a donor contain-
ing the leptin gene under control of a promoter that is
active in mammalian cells (Figure 3).
Concluding remarks
In this review, we have presented approaches, notably the
MultiBac technology, for producing important eukaryotic
protein complexes that were hitherto not amenable to
structural and functional analysis. Molecules as complex
as the APC/C have been successfully produced using Multi-
Bac, enabling structure determination and architectural
dissection. More recently, the technology concepts under-
lying MultiBac have been extended to mammalian gene
delivery and even gene therapy, and we anticipate that
many more applications will benefit from this approach.
In addition, optimized multigene expression technolo-
gies that involve polyproteins and library approaches have
become available, and the polyprotein technology has been
integrated into MultiBac, increasing the prowess of the
system. A beneficial next step could be to incorporate also
library approaches such as CoESPRIT [31] (Box 1). This
could conceivably accelerate the discovery of protein–pro-
tein interactions for complexes that rely on a eukaryotic
expression host. Protein–protein interactions are inten-
sively studied in the pharmaceutical industry, with the
aim to identify intermolecular surfaces that can be tar-
geted for drug design [53]. It will be interesting to see
whether this field of discovery will also benefit from the
MultiBac technology in the future.
Considerable effort has been devoted to generating
custom-designed insect and mammalian host cells, which
provide specialized functionalities such as humanized gly-
cosylation [54]. A logical extension of the MultiBac system
will be to make use of these host cells, for example to
produce antibodies with a close-to-human glycosylation
pattern for therapeutic applications.
The MultiBac system continues to catalyze progress in
many fields of research. An entirely open question is where
the limits of the MultiBac production technology may be.
For instance, the transcriptional machinery producing
eukaryotic mRNAs contains, in addition to the genetic
DNA template, a stunning 100 proteins organized in multi-
subunit complexes. It may seem frivolous to set out with
MultiBac to address this complexity structurally and func-
tionally in a defined, fully recombinant setup. Nonetheless,
the first glimpses of the molecular architectures involved
are emerging: the Mediator head, produced by MultiBac,
has been crystallized and the structure resolved. The stage
is set. Exciting times are ahead of us.
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